The hemogenic endothelium: a critical source for the generation of PSC-derived hematopoietic stem and progenitor cells

L Lange, M Morgan, A Schambach - Cellular and Molecular Life Sciences, 2021 - Springer
In vitro generation of hematopoietic cells and especially hematopoietic stem cells (HSCs)
from human pluripotent stem cells (PSCs) are subject to intensive research in recent …

Hematopoietic cells from pluripotent stem cells: hope and promise for the treatment of inherited blood disorders

I Rao, L Crisafulli, M Paulis, F Ficara - Cells, 2022 - mdpi.com
Inherited blood disorders comprise a large spectrum of diseases due to germline mutations
in genes with key function in the hematopoietic system; they include immunodeficiencies …

[PDF][PDF] Potently cytotoxic natural killer cells initially emerge from erythro-myeloid progenitors during mammalian development

C Dege, KH Fegan, JP Creamer, MM Berrien-Elliott… - Developmental cell, 2020 - cell.com
Natural killer (NK) cells are a critical component of the innate immune system. However,
their ontogenic origin has remained unclear. Here, we report that NK cell potential first arises …

Identification of a retinoic acid-dependent haemogenic endothelial progenitor from human pluripotent stem cells

SA Luff, JP Creamer, S Valsoni, C Dege, R Scarfò… - Nature cell …, 2022 - nature.com
The generation of haematopoietic stem cells (HSCs) from human pluripotent stem cells
(hPSCs) is a major goal for regenerative medicine. During embryonic development, HSCs …

[PDF][PDF] SOX17 integrates HOXA and arterial programs in hemogenic endothelium to drive definitive lympho-myeloid hematopoiesis

HS Jung, G Uenishi, MA Park, P Liu, K Suknuntha… - Cell reports, 2021 - cell.com
SOX17 has been implicated in arterial specification and the maintenance of hematopoietic
stem cells (HSCs) in the murine embryo. However, knowledge about molecular pathways …

De novo generation of human hematopoietic stem cells from pluripotent stem cells for cellular therapy

J Ding, Y Li, A Larochelle - Cells, 2023 - mdpi.com
The ability to manufacture human hematopoietic stem cells (HSCs) in the laboratory holds
enormous promise for cellular therapy of human blood diseases. Several differentiation …

Recent updates on induced pluripotent stem cells in hematological disorders

M Wattanapanitch - Stem cells international, 2019 - Wiley Online Library
Over the past decade, enormous progress has been made in the field of induced pluripotent
stem cells (iPSCs). Patients' somatic cells such as skin fibroblasts or blood cells can be used …

Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

JL Fowler, SL Zheng, A Nguyen, A Chen, X Xiong… - Developmental Cell, 2024 - cell.com
The developmental origin of blood-forming hematopoietic stem cells (HSCs) is a
longstanding question. Here, our non-invasive genetic lineage tracing in mouse embryos …

[HTML][HTML] Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in human pluripotent stem cell cultures

II Slukvin, GI Uenishi - Experimental hematology, 2019 - Elsevier
Human pluripotent stem cells (hPSCs) have been suggested as a potential source for the de
novo production of blood cells for transfusion, immunotherapies, and transplantation …

Human induced pluripotent stem cell–derived macrophages for unraveling human macrophage biology

H Zhang, MP Reilly - Arteriosclerosis, thrombosis, and vascular …, 2017 - Am Heart Assoc
Despite a substantial appreciation for the critical role of macrophages in cardiometabolic
diseases, understanding of human macrophage biology has been hampered by the lack of …